ORBIMED ADVISORS LLC Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$11.4T
Holdings
148
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (148 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —MERSANA THERAPEUTICS INC | 773,348 | $20.6B | 0.18% | |
| 102 | 290ACHINOOK THERAPEUTICS INC | 1,250,001 | $19.8B | 0.17% | |
| 103 | LRMRLARIMAR THERAPEUTICS INC | 886,560 | $19.0B | 0.17% | |
| 104 | TEVATEVA PHARMACEUTICAL INDS LTD | 1,935,200 | $18.7B | 0.16% | |
| 105 | VRCAVERRICA PHARMACEUTICALS INC | 1,479,733 | $17.0B | 0.15% | |
| 106 | —SYROS PHARMACEUTICALS INC | 1,562,500 | $17.0B | 0.15% | |
| 107 | PCVXVAXCYTE INC | 630,260 | $16.7B | 0.15% | |
| 108 | MISTMILESTONE PHARMACEUTICALS IN | 2,493,109 | $16.7B | 0.15% | |
| 109 | CMPSCOMPASS PATHWAYS PLC | 350,000 | $16.7B | 0.15% | |
| 110 | IMGNEURIMMUNOGEN INC | 2,553,900 | $16.5B | 0.14% | |
| 111 | —ZYMEWORKS INC | 317,002 | $15.0B | 0.13% | |
| 112 | PHGEBIOMX INC | 2,313,489 | $14.8B | 0.13% | |
| 113 | VTGNUSDVISTAGEN THERAPEUTICS INC | 7,500,000 | $14.6B | 0.13% | |
| 114 | RLAYRELAY THERAPEUTICS INC | 350,000 | $14.5B | 0.13% | |
| 115 | ACADACADIA PHARMACEUTICALS INC | 265,772 | $14.2B | 0.12% | |
| 116 | PRAXPRAXIS PRECISION MEDICINES I | 255,600 | $14.1B | 0.12% | |
| 117 | ALXOALX ONCOLOGY HLDGS INC | 150,000 | $12.9B | 0.11% | |
| 118 | BLUBELLUS HEALTH INC NEW | 4,189,593 | $12.6B | 0.11% | |
| 119 | GILDGILEAD SCIENCES INC | 192,200 | $11.2B | 0.10% | |
| 120 | —AVROBIO INC | 793,712 | $11.1B | 0.10% | |
| 121 | TARAPROTARA THERAPEUTICS INC | 450,000 | $10.9B | 0.10% | |
| 122 | VTRSVIATRIS INC | 535,149 | $10.0B | 0.09% | |
| 123 | NRIXNURIX THERAPEUTICS INC | 300,000 | $9.9B | 0.09% | |
| 124 | LUNGPULMONX CORP | 125,000 | $8.6B | 0.08% | |
| 125 | —STRONGBRIDGE BIOPHARMA PLC | 3,489,369 | $8.5B | 0.07% | |
| 126 | INZYINOZYME PHARMA INC | 400,400 | $8.3B | 0.07% | |
| 127 | NBTXNANOBIOTIX SA | 500,000 | $8.3B | 0.07% | |
| 128 | HCATHEALTH CATALYST INC | 179,598 | $7.8B | 0.07% | |
| 129 | —TCR2 THERAPEUTICS INC | 249,279 | $7.7B | 0.07% | |
| 130 | STROSUTRO BIOPHARMA INC | 350,000 | $7.6B | 0.07% | |
| 131 | COGTCOGENT BIOSCIENCES INC | 655,000 | $7.4B | 0.06% | |
| 132 | DYNDYNE THERAPEUTICS INC | 350,000 | $7.3B | 0.06% | |
| 133 | OMGBPOUTSET MED INC | 125,000 | $7.1B | 0.06% | |
| 134 | ASNSUSDX4 PHARMACEUTICALS INC | 1,086,493 | $7.0B | 0.06% | |
| 135 | —HEALTH SCIENCES ACQ CORP 2 | 500,000 | $6.4B | 0.06% | |
| 136 | —AKOUOS INC | 315,000 | $6.2B | 0.05% | |
| 137 | EPIEURESSA PHARMA INC | 460,500 | $5.5B | 0.05% | |
| 138 | FDMT4D MOLECULAR THERAPEUTICS IN | 125,000 | $5.2B | 0.05% | |
| 139 | —AERPIO PHARMACEUTICALS INC | 5,193,946 | $5.1B | 0.04% | |
| 140 | —SYNLOGIC INC | 2,029,996 | $4.4B | 0.04% | |
| 141 | TOCAEURFORTE BIOSCIENCES INC | 92,200 | $3.4B | 0.03% | |
| 142 | IFRXINFLARX NV | 556,025 | $2.8B | 0.02% | |
| 143 | MASS908 DEVICES INC | 40,000 | $2.3B | 0.02% | |
| 144 | SELBUSDSELECTA BIOSCIENCES INC | 539,169 | $1.6B | 0.01% | |
| 145 | PPBTPURPLE BIOTECH LTD | 346,197 | $1.3B | 0.01% | |
| 146 | —CALITHERA BIOSCIENCES INC | 250,300 | $1.2B | 0.01% | Put |
| 147 | —NOVUS THERAPEUTICS INC | 73,650 | $1.1B | 0.01% | |
| 148 | BMY-RBRISTOL-MYERS SQUIBB CO | 400,000 | $276.0M | 0.00% |
PreviousPage 2 of 2